Navigation Links
Indiana University to host national biorepository for gene therapy
Date:6/19/2008

INDIANAPOLIS Indiana University School of Medicine will be home to the nation's sole National Gene Vector Biorepository and Coordinating Center (NGVB) for gene therapy research with a three-year, $3 million grant from the National Institutes of Health.

The program is directed by Kenneth Cornetta, M.D, Joe C. Christian Professor and chair of Medical and Molecular Genetics and professor of medicine and of microbiology and immunology. The three year grant to the School of Medicine was effective June 15.

"This center will continue the IU School of Medicine's history of providing critical resources to gene therapy researchers, who are working to find treatments for some of our most difficult diseases," said Dr. Cornetta.

Researchers use gene vectors, such as disabled viruses, to carry genetic materials in the body in hopes of treating or preventing disease. For example, genes important for fighting infections may be inserted into immune system cells that have been rendered inactive by genetic mutations.

The NGVB at Indiana University will help university scientists share research information and substances to promote discoveries, patient safety and compliance with regulations of the Food and Drug Administration. The NGVB's services will include maintaining a warehouse of important reagents, disseminating the results of safety studies, and the storage of biological materials and patient specimens in accordance with FDA regulations. The IU center will also conduct studies of the safety of various gene therapy techniques, said Dr. Cornetta.

"The new biorepository and center will help leverage information-sharing and expertise across the gene therapy research community," said Barbara M. Alving, M.D., director of the National Center for Research Resources, the NIH center that is funding the grant. "By coordinating preclinical studies, this resource will maximize NIH's investment in gene vector research and help translate new knowledge into tangible benefits for patients."

Scientists are using gene transfer techniques in studies involving a broad range of diseases including cancer, heart disease, cystic fibrosis, immune disorders including arthritis, and infectious diseases. An NIH database lists more than 500 such trials currently under way.

The NGVB replaces the National Gene Vector Laboratory and Coordinating Center at the IU School of Medicine, which provided gene therapy vectors for use in clinical trials. Indiana University continues to provide gene therapy vectors under contracts with the National Cancer Institute and the National Heart Lung and Blood Institute.


'/>"/>

Contact: Eric Schoch
eschoch@iupui.edu
317-274-7722
Indiana University
Source:Eurekalert

Related medicine news :

1. The role of giving explored by Indiana University physician-author
2. HHS Takes Action to Help Medicare Beneficiaries and Providers in Iowa and Indiana
3. Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundations Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow in Indianapolis is Participating
4. AARP Indiana Key Vote News Alert: AARP Dismayed by Senate Vote to Block Medicare Improvement Bill
5. National Pharmaceutical Company to Sponsor Popular Indianapolis Walk
6. Lilly to Provide Aid to Indiana Tornado and Flood Victims
7. Publicis Indianapolis and St. Vincent Hospital Win the Gold
8. Indiana University research at the American College of Sports Medicine annual conference
9. NIH awards $25M clinical research grant to Indiana U for statewide initiative
10. Hear Indiana Announces Talk*Walk*Run 2008
11. Skanska Opens Indianapolis Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: